Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aurobindo to buy parts of Sandoz US from Novartis for $900m
Aurobindo Pharma USA has agreed to acquire selected portions of Sandoz US portfolio from Novartis for $900m of cash and $100m of potential earn-outs.
Drug Manufacturing
-
06 Sep 2018
-
19 Jul 2018
EUSA Pharma to buy global rights of Janssen’s Sylvant for $115m
UK-based EUSA Pharma has agreed to acquire the global rights of Sylvant (siltuximab), a rare blood disorder drug, from Janssen Sciences Ireland UC for $115m.
-
18 Jul 2018
Clinigen acquires global rights to Proleukin outside US
Clinigen Group has acquired the global rights to Proleukin (aldesleukin, recombinant interleukin-2) outside the United States from Novartis.
-
11 Jul 2018
US FTC approves Takeda’s $62bn acquisition of Shire
Takeda Pharmaceutical’s £45.3bn ($62bn) acquisition of Shire has been unconditionally approved by the US Federal Trade Commission (FTC).